Interleukin 10 is not essential for survival or for modulating T-cell function after injury

被引:11
作者
Kavanagh, EK [1 ]
Kell, MR [1 ]
Goebel, A [1 ]
Soberg, CC [1 ]
Mannick, JA [1 ]
Lederer, JA [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg Immunol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0039-6060(99)70192-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Interleukin 10 (Il-10) is thought to be protective injury and sepsis. However, we recently reported that Il-10 antagonism can be beneficial after burn injury. This study used IL-10-deficient (IL-10 [-/-]) mice to further define the role of IL-10 after injury. Methods. Wild-type (WT) C57BL/6 or Il-10 (-/-) mice were anesthetized, sham or burn injured, and immunized subcutaneously with a T-cell-dependent protein antigen. Ten days later antigen-specific serum antibody isotype formation was measured by enzyme-linked immunosorbent assay. In addition, antigen-stimulated splenic T-cell proliferation and cytokine production (interleukin 2, interferon gamma, and tumor necrosis factor-alpha) were measured. Results. Burn-injured IL-10 (-/-) mice survival (80%) was equivalent to that of burn-injured WT mice (74%). An injury-dependent loss of T-helper 1 (Th1)-type antibody isotype (IgG2a) formation occurred in both WT and IL-10 (-/-) mice. In vitro studies indicated that burn injury caused reduced antigen-stimulated splenic T-cell proliferation and Th 1-type (interleukin 2 and interferon gamma) cytokine production in WT and IL-10 (-/-) mice, whereas burn-injured Il-10 (-/-) mice produced high levels of antigen-stimulated tumor necrosis factor-alpha. Conclusions. Il-10 is not essential for survival after burn injury or for several injury-induced changes in adaptive immune function, including Th1-type antibody isotype formation, T-cell proliferation, and Th1-type cytokine production.
引用
收藏
页码:456 / 462
页数:7
相关论文
共 24 条
[1]  
AYALA A, 1993, ARCH SURG-CHICAGO, V128, P89
[2]   TOWARD AN EPIDEMIOLOGY AND NATURAL-HISTORY OF SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME) [J].
BONE, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24) :3452-3455
[3]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[4]   Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling [J].
Cope, AP ;
Liblau, RS ;
Yang, XD ;
Congia, M ;
Laudanna, C ;
Schreiber, RD ;
Probert, L ;
Kollias, G ;
McDevitt, HO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1573-1584
[5]   Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury [J].
Engles, RE ;
Huber, TS ;
Zander, DS ;
Hess, PJ ;
Welborn, MB ;
Moldawer, LL ;
Seeger, JM .
JOURNAL OF SURGICAL RESEARCH, 1997, 69 (02) :425-428
[6]   Acute ethanol exposure prior to thermal injury results in decreased T-cell responses mediated in part by increased production of IL-6 [J].
Faunce, DE ;
Gregory, MS ;
Kovacs, EJ .
SHOCK, 1998, 10 (02) :135-140
[7]   REGULATION BY INTERFERON-ALPHA OF IMMUNOGLOBULIN ISOTYPE SELECTION AND LYMPHOKINE PRODUCTION IN MICE [J].
FINKELMAN, FD ;
SVETIC, A ;
GRESSER, I ;
SNAPPER, C ;
HOLMES, J ;
TROTTA, PP ;
KATONA, IM ;
GAUSE, WC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :1179-1188
[8]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550
[9]  
GILBERT KM, 1990, J IMMUNOL, V144, P2063
[10]  
GREENBERGER MJ, 1995, J IMMUNOL, V155, P722